Results 161 to 170 of about 3,269,800 (189)
Some of the next articles are maybe not open access.
Liver regeneration and liver metastasis
Seminars in Cancer Biology, 2021Surgical resection for primary and secondary hepatic neoplasms provides the best chance of cure. Advanced surgical techniques such as portal vein embolisation, two-staged hepatectomy and associated liver partition and portal vein ligation for staged-hepatectomy (ALPPS) have facilitated hepatic resection in patients with previously unresectable, bi ...
Ali W. Majeed +3 more
openaire +3 more sources
Liver Transplantation for Liver Tumors [PDF]
, 1986 Liver transplantation principally can be considered as a suitable form of treatment for any patient with progressive or end-stage liver disease, when no other standard therapy is available. The two main categories of indications are liver cirrhosis with severe complications from functional deterioration and primary malignancies of the liver.
Rudolf Pichlmayr +3 more
openaire +2 more sources
Fatty Liver and Liver Transplantation
Clinics in Liver Disease, 2009Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis are common complications of overnutrition and obesity. In the setting of worsening epidemics of obesity in developed and developing countries, the global prevalence and impact of NAFLD seems likely to increase.
Michael Charlton +2 more
openaire +3 more sources
Segmentation of liver and liver tumor for the Liver-Workbench
SPIE Proceedings, 2011Robust and efficient segmentation tools are important for the quantification of 3D liver and liver tumor volumes which can greatly help clinicians in clinical decision-making and treatment planning. A two-module image analysis procedure which integrates two novel semi-automatic algorithms has been developed to segment 3D liver and liver tumors from ...
Feng Ding +7 more
openaire +2 more sources
The Lancet, 2021
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C infection, autoimmune diseases, cholestatic diseases, and iron or copper overload.
Ginès, Pere +5 more
openaire +3 more sources
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C infection, autoimmune diseases, cholestatic diseases, and iron or copper overload.
Ginès, Pere +5 more
openaire +3 more sources
Liver transplantation for liver cancer
World Journal of Surgery, 1982AbstractResults in the first 100 orthotopic liver allografts performed in the Cambridge‐King's College Hospital series (1968–1980) are reported. Twenty‐two patients survived beyond a year (age range, 16–59 years). Of these, 12 were cirrhotics and 10 were primary malignancies. Of the cirrhotics, 10 are alive, with the 2 deaths resulting from cholangitis.
openaire +3 more sources
Current Opinion in Gastroenterology, 1992
At the close of the 20th century, a selection of articles published in 1999 with relevance to liver pathology reflects the wealth of technological and intellectual progress made during the span of the century. Immunohistochemical staining for hepatitis B virus antigens focused attention on a correlation between cytoplasmic expression of core antigen in
openaire +5 more sources
At the close of the 20th century, a selection of articles published in 1999 with relevance to liver pathology reflects the wealth of technological and intellectual progress made during the span of the century. Immunohistochemical staining for hepatitis B virus antigens focused attention on a correlation between cytoplasmic expression of core antigen in
openaire +5 more sources
Liver Transplantation for Alcoholic Liver Disease
Transplantation, 2016Alcohol-related liver disease is the second most frequent indication for liver transplantation (LT), yet as many as 90% to 95% of patients with alcohol-related end-stage liver disease are never formally evaluated for LT. Furthermore, despite its significance as a cause of chronic liver disease and indication for LT, it has received little attention in ...
Addolorato, Giovanni +9 more
openaire +3 more sources
Endocrinology and Metabolism Clinics of North America, 2015
Lipid lowering, particularly with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors ("statins"), reduces the risk of cardiovascular disease. Patients with chronic liver disease present challenges to the use of lipid medications. In the case of most liver disorders, the concern has been one of safety.
Edward A. Gill +2 more
openaire +5 more sources
Lipid lowering, particularly with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors ("statins"), reduces the risk of cardiovascular disease. Patients with chronic liver disease present challenges to the use of lipid medications. In the case of most liver disorders, the concern has been one of safety.
Edward A. Gill +2 more
openaire +5 more sources